Finance

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

Foley & Lardner's Nathaniel Lacktman and Louis Lehot discuss which categories of digital health hold the most potential for M&As and why in this contributed piece.

Researchers will study how Rion’s Purified Exosome Product may aid service members with pulmonary disease via a collaboration with the U.S. Army Medical Research Institute and Mayo Clinic, says Dr. Atta Behfar, Rion’s CEO and cofounder.

The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.

HIMSS23 Europe Startup PitchFest winner Direct Diagnostics' CEO Elsemieke Hackenitz says the company's preventive-healthcare solution is scaling as it shifts its focus toward a B2B model.

The digital therapeutics company and virtual chronic pain-management program will combine their offerings to create a digital care-management solution for chronic pain.

The acquisition brings UpLift's offerings to Illinois, New York, Pennsylvania, Texas and California, helping to speed up its ability to expand nationally. 

Carebook reports record revenue and the first quarter of positive adjusted EBITDA, while Cue Health sees large net and adjusted EBITDA losses.

National Taiwan University Hospital's vice superintendent, Dr I-Rue Lai, relays the health system's ambition to be a fully value-based, data-enabled care provider, which includes interoperability, internally and with external providers.